| Product details | Supply Impact Dates | Further Details |
|---|---|---|
ANZATAX paclitaxel 100mg/16.7mLAUST R: 106458 Active Ingredients: paclitaxel Dosage From: Injection, concentrated |
From: 01 Mar 2027 To: 30 Apr 2027 |
Shortage Status: Anticipated Availability: Available Reason: Manufacturing |
PACLITAXEL ACCORD paclitaxel 300 mg/50 mLAUST R: 219556 Active Ingredients: paclitaxel Dosage From: Injection, concentrated |
From: 02 Sep 2026 To: 15 Oct 2026 |
Shortage Status: Resolved Availability: Available Reason: Manufacturing |
ANZATAX paclitaxel 30mg/5mLAUST R: 50578 Active Ingredients: paclitaxel Dosage From: Injection, concentrated |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mgAUST R: 328527 Active Ingredients: paclitaxel Dosage From: Injection, powder for |
From: 05 Feb 2026 To: 08 Jan 2027 |
Shortage Status: Current Availability: Limited Availability Reason: Manufacturing |
ABRAXANE nanoparticle albumin-bound paclitaxel 100 mgAUST R: 133500 Active Ingredients: paclitaxel Dosage From: Injection, powder for |
From: 04 May 2026 To: 04 May 2026 |
Shortage Status: Resolved Availability: Available Reason: Unexpected increase in demand due to other sponsors unable to supply |
PACLITAXEL EBEWE paclitaxel 300 mg/50 mLAUST R: 98551 Active Ingredients: paclitaxel Dosage From: Injection, concentrated |
From: To: |
Shortage Status: Discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability |
ANZATAX paclitaxel 150mg/25mLAUST R: 50577 Active Ingredients: paclitaxel Dosage From: Injection, concentrated |
From: 12 Oct 2026 To: 04 Dec 2026 |
Shortage Status: Current Availability: Limited Availability Reason: Manufacturing |